NEW MJ NEWS

AbbVie to Present at the Goldman Sachs 44th Annual Global Healthcare Conference

AbbVie (NYSE: ABBV) will participate in the Goldman Sachs 44th Annual Global Healthcare Conference on Wednesday, June 14, 2023. Robert A. Michael, vice chairman and president, Jeffrey R. Stewart, executive vice president, chief commercial officer and Roopal Thakkar, senior vice president, development and regulatory affairs and chief medical officer, will present at 10:00 a.m. Central time.

A live audio webcast of the presentation will be accessible through AbbVie’s Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology and gastroenterology, in addition to products and services across our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

View original content:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-goldman-sachs-44th-annual-global-healthcare-conference-301837200.html

SOURCE AbbVie


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$MDBX Beefs Up Security… BIG TIME

Medbox Adds Former FBI Assistant Director of Security to Its Board LOS…

Neptune Wellness Solutions Inc. (NEPT) Granted U.S. Patent for its Unique Organic Solvent Cannabis Extraction Process

Neptune Wellness Granted U.S. Patent for its Unique Organic Solvent Cannabis Extraction…

Dragonfly Therapeutics Announces AbbVie (ABBV) Opt-In of TriNKET™ Immunotherapy Drug Candidate

Dragonfly Therapeutics Announces AbbVie Opt-In of TriNKET™ Immunotherapy Drug Candidate Dragonfly Therapeutics…

Ascend Wellness Holdings, Inc. (AAWH) Participation in Upcoming Conferences in April

AWH Announces Participation in Upcoming Conferences in April Ascend Wellness Holdings, Inc.…